Cargando…
The Pharmacological Mechanism of Curcumin against Drug Resistance in Non-Small Cell Lung Cancer: Findings of Network Pharmacology and Bioinformatics Analysis
The pharmacological mechanism of curcumin against drug resistance in non-small cell lung cancer (NSCLC) remains unclear. This study aims to summarize the genes and pathways associated with curcumin action as an adjuvant therapy in NSCLC using network pharmacology, drug-likeness, pharmacokinetics, fu...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586741/ https://www.ncbi.nlm.nih.gov/pubmed/36276869 http://dx.doi.org/10.1155/2022/5926609 |
_version_ | 1784813747183812608 |
---|---|
author | Xie, Han Huang, Guirui Zou, Jianhua Zhu, Qianru Liang, Zimao Huang, Xingxing Zhai, Xiangyang Zhang, Ruonan Chen, Bi Li, Keshuai Sui, Xinbing Yu, Lili Cui, Hongsheng Wu, Qibiao |
author_facet | Xie, Han Huang, Guirui Zou, Jianhua Zhu, Qianru Liang, Zimao Huang, Xingxing Zhai, Xiangyang Zhang, Ruonan Chen, Bi Li, Keshuai Sui, Xinbing Yu, Lili Cui, Hongsheng Wu, Qibiao |
author_sort | Xie, Han |
collection | PubMed |
description | The pharmacological mechanism of curcumin against drug resistance in non-small cell lung cancer (NSCLC) remains unclear. This study aims to summarize the genes and pathways associated with curcumin action as an adjuvant therapy in NSCLC using network pharmacology, drug-likeness, pharmacokinetics, functional enrichment, protein-protein interaction (PPI) analysis, and molecular docking. Prognostic genes were identified from the curcumin-NSCLC intersection gene set for the following drug sensitivity analysis. Immunotherapy, chemotherapy, and targeted therapy sensitivity analyses were performed using external cohorts (GSE126044 and IMvigor210) and the CellMiner database. 94 curcumin-lung adenocarcinoma (LUAD) hub targets and 41 curcumin-lung squamous cell carcinoma (LUSC) hub targets were identified as prognostic genes. The anticancer effect of curcumin was observed in KEGG pathways involved with lung cancer, cancer therapy, and other cancers. Among the prognostic curcumin-NSCLC intersection genes, 20 LUAD and 8 LUSC genes were correlated with immunotherapy sensitivity in the GSE126044 NSCLC cohort; 30 LUAD and 13 LUSC genes were associated with immunotherapy sensitivity in the IMvigor210 cohort; and 12 LUAD and 13 LUSC genes were related to chemosensitivity in the CellMiner database. Moreover, 3 LUAD and 5 LUSC genes were involved in the response to targeted therapy in the CellMiner database. Curcumin regulates drug sensitivity in NSCLC by interacting with cell cycle, NF-kappa B, MAPK, Th17 cell differentiation signaling pathways, etc. Curcumin in combination with immunotherapy, chemotherapy, or targeted drugs has the potential to be effective for drug-resistant NSCLC. The findings of our study reveal the relevant key signaling pathways and targets of curcumin as an adjuvant therapy in the treatment of NSCLC, thus providing pharmacological evidence for further experimental research. |
format | Online Article Text |
id | pubmed-9586741 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-95867412022-10-22 The Pharmacological Mechanism of Curcumin against Drug Resistance in Non-Small Cell Lung Cancer: Findings of Network Pharmacology and Bioinformatics Analysis Xie, Han Huang, Guirui Zou, Jianhua Zhu, Qianru Liang, Zimao Huang, Xingxing Zhai, Xiangyang Zhang, Ruonan Chen, Bi Li, Keshuai Sui, Xinbing Yu, Lili Cui, Hongsheng Wu, Qibiao Evid Based Complement Alternat Med Research Article The pharmacological mechanism of curcumin against drug resistance in non-small cell lung cancer (NSCLC) remains unclear. This study aims to summarize the genes and pathways associated with curcumin action as an adjuvant therapy in NSCLC using network pharmacology, drug-likeness, pharmacokinetics, functional enrichment, protein-protein interaction (PPI) analysis, and molecular docking. Prognostic genes were identified from the curcumin-NSCLC intersection gene set for the following drug sensitivity analysis. Immunotherapy, chemotherapy, and targeted therapy sensitivity analyses were performed using external cohorts (GSE126044 and IMvigor210) and the CellMiner database. 94 curcumin-lung adenocarcinoma (LUAD) hub targets and 41 curcumin-lung squamous cell carcinoma (LUSC) hub targets were identified as prognostic genes. The anticancer effect of curcumin was observed in KEGG pathways involved with lung cancer, cancer therapy, and other cancers. Among the prognostic curcumin-NSCLC intersection genes, 20 LUAD and 8 LUSC genes were correlated with immunotherapy sensitivity in the GSE126044 NSCLC cohort; 30 LUAD and 13 LUSC genes were associated with immunotherapy sensitivity in the IMvigor210 cohort; and 12 LUAD and 13 LUSC genes were related to chemosensitivity in the CellMiner database. Moreover, 3 LUAD and 5 LUSC genes were involved in the response to targeted therapy in the CellMiner database. Curcumin regulates drug sensitivity in NSCLC by interacting with cell cycle, NF-kappa B, MAPK, Th17 cell differentiation signaling pathways, etc. Curcumin in combination with immunotherapy, chemotherapy, or targeted drugs has the potential to be effective for drug-resistant NSCLC. The findings of our study reveal the relevant key signaling pathways and targets of curcumin as an adjuvant therapy in the treatment of NSCLC, thus providing pharmacological evidence for further experimental research. Hindawi 2022-10-14 /pmc/articles/PMC9586741/ /pubmed/36276869 http://dx.doi.org/10.1155/2022/5926609 Text en Copyright © 2022 Han Xie et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Xie, Han Huang, Guirui Zou, Jianhua Zhu, Qianru Liang, Zimao Huang, Xingxing Zhai, Xiangyang Zhang, Ruonan Chen, Bi Li, Keshuai Sui, Xinbing Yu, Lili Cui, Hongsheng Wu, Qibiao The Pharmacological Mechanism of Curcumin against Drug Resistance in Non-Small Cell Lung Cancer: Findings of Network Pharmacology and Bioinformatics Analysis |
title | The Pharmacological Mechanism of Curcumin against Drug Resistance in Non-Small Cell Lung Cancer: Findings of Network Pharmacology and Bioinformatics Analysis |
title_full | The Pharmacological Mechanism of Curcumin against Drug Resistance in Non-Small Cell Lung Cancer: Findings of Network Pharmacology and Bioinformatics Analysis |
title_fullStr | The Pharmacological Mechanism of Curcumin against Drug Resistance in Non-Small Cell Lung Cancer: Findings of Network Pharmacology and Bioinformatics Analysis |
title_full_unstemmed | The Pharmacological Mechanism of Curcumin against Drug Resistance in Non-Small Cell Lung Cancer: Findings of Network Pharmacology and Bioinformatics Analysis |
title_short | The Pharmacological Mechanism of Curcumin against Drug Resistance in Non-Small Cell Lung Cancer: Findings of Network Pharmacology and Bioinformatics Analysis |
title_sort | pharmacological mechanism of curcumin against drug resistance in non-small cell lung cancer: findings of network pharmacology and bioinformatics analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586741/ https://www.ncbi.nlm.nih.gov/pubmed/36276869 http://dx.doi.org/10.1155/2022/5926609 |
work_keys_str_mv | AT xiehan thepharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis AT huangguirui thepharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis AT zoujianhua thepharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis AT zhuqianru thepharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis AT liangzimao thepharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis AT huangxingxing thepharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis AT zhaixiangyang thepharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis AT zhangruonan thepharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis AT chenbi thepharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis AT likeshuai thepharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis AT suixinbing thepharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis AT yulili thepharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis AT cuihongsheng thepharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis AT wuqibiao thepharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis AT xiehan pharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis AT huangguirui pharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis AT zoujianhua pharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis AT zhuqianru pharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis AT liangzimao pharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis AT huangxingxing pharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis AT zhaixiangyang pharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis AT zhangruonan pharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis AT chenbi pharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis AT likeshuai pharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis AT suixinbing pharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis AT yulili pharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis AT cuihongsheng pharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis AT wuqibiao pharmacologicalmechanismofcurcuminagainstdrugresistanceinnonsmallcelllungcancerfindingsofnetworkpharmacologyandbioinformaticsanalysis |